Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
SUGP - SU Group Holdings Ltd. - Stock Price Chart
TickerSUGP [NASD]
CompanySU Group Holdings Ltd.
CountryHong Kong
IndustrySecurity & Protection Services
Market Cap30.08MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own72.91%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.06%Earnings-
Analyst Recom-Target Price-
Avg Volume332.15K52W Range1.83 - 5.86
SU Group Holdings Ltd. engages in the provision of integrated security-related services. Its services include threat detection, traffic and vehicle control, pedestrian access control, ELV system, security personnel, and vocational training. It operates through the Security-related Engineering Services, and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.
STRO - Sutro Biopharma Inc - Stock Price Chart
TickerSTRO [NASD, RUT]
CompanySutro Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap287.68MEPS (ttm)-1.79
P/E-EPS this Y-101.39%
Forward P/E-EPS next Y9.09%
PEG-EPS past 5Y21.96%
P/S1.87EPS next 5Y-12.88%
P/B1.52EPS Q/Q183.59%
Dividend-Sales Q/Q1217.44%
Insider Own4.09%Inst Own80.16%
Insider Trans-0.39%Inst Trans9.73%
Short Float2.96%EarningsMar 26/b
Analyst Recom1.20Target Price12.89
Avg Volume997.01K52W Range2.01 - 6.13
Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Srinivasan VenkateshCHIEF TECH OP OFFICERApr 11 '24Option Exercise0.0021,250037,704Apr 12 05:59 PM
FITZPATRICK LINDA ACHIEF PEOPLE & COMM. OFFICERMar 05 '24Option Exercise0.008,750076,060Mar 07 07:12 PM
NEWELL WILLIAM JCEOMar 05 '24Option Exercise0.0018,7500226,893Mar 07 04:31 PM
ALBINI EDWARD CCFO AND SECRETARYMar 05 '24Option Exercise0.008,7500109,843Mar 07 04:21 PM
ALBINI EDWARD CCFO AND SECRETARYMar 04 '24Option Exercise0.009,1250104,565Mar 06 04:18 PM
BMTX - BM Technologies Inc - Stock Price Chart
TickerBMTX [AMEX]
CompanyBM Technologies Inc
CountryUSA
IndustrySoftware - Application
Market Cap21.11MEPS (ttm)-1.50
P/E-EPS this Y41.78%
Forward P/E21.88EPS next Y109.16%
PEG-EPS past 5Y-
P/S0.38EPS next 5Y-
P/B0.67EPS Q/Q2.28%
Dividend-Sales Q/Q-5.26%
Insider Own30.33%Inst Own30.14%
Insider Trans0.00%Inst Trans-11.26%
Short Float0.75%EarningsApr 03/a
Analyst Recom1.67Target Price5.08
Avg Volume10.84K52W Range1.41 - 3.85
BM Technologies, Inc. is a technology company that provides banking services through its partner banks. It offers a mobile banking platform in the U.S. that provides access to checking and savings accounts, personal loans and credit cards. The company's operating model enables partner banks to provide banking services to low and middle-income Americans who have been left behind by the fee model of traditional banks. The company was founded by Luvleen Sidhu in 2016 and is headquartered in Wayne, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Donahue James M.President & CTOMar 31 '24Option Exercise0.0018,750083,542Apr 02 04:56 PM
Sidhu LuvleenChief Executive OfficerMar 31 '24Option Exercise0.0025,0000711,441Apr 02 04:58 PM
Dullinger James FrancisChief Financial OfficerMar 31 '24Option Exercise0.007,500012,421Apr 02 05:00 PM
Dullinger James FrancisChief Financial OfficerMar 09 '24Option Exercise0.001,60005,366Mar 12 04:03 PM
Donahue James M.President & CTOJan 04 '24Option Exercise0.0012,004067,275Mar 06 04:01 PM
KOD - Kodiak Sciences Inc - Stock Price Chart
TickerKOD [NASD, RUT]
CompanyKodiak Sciences Inc
CountryUSA
IndustryBiotechnology
Market Cap185.40MEPS (ttm)-4.97
P/E-EPS this Y10.59%
Forward P/E-EPS next Y0.08%
PEG-EPS past 5Y-12.42%
P/S-EPS next 5Y12.40%
P/B0.70EPS Q/Q15.79%
Dividend-Sales Q/Q-
Insider Own7.36%Inst Own76.78%
Insider Trans0.00%Inst Trans2.83%
Short Float5.06%EarningsMar 28/b
Analyst Recom3.57Target Price4.25
Avg Volume829.18K52W Range1.37 - 9.80
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BORGESON JOHN A.See RemarksJun 16 '23Sale9.232,74925,373178,077Jun 16 08:25 PM
EHRLICH JASONSee RemarksJun 16 '23Sale9.232,25820,84161,924Jun 16 08:27 PM
BORGESON JOHN A.See RemarksJun 14 '23Sale9.421,44813,640175,332Jun 16 08:25 PM
EHRLICH JASONSee RemarksJun 14 '23Sale9.421,13210,66358,688Jun 16 08:27 PM
LXFR - Luxfer Holdings PLC - Stock Price Chart
TickerLXFR [NYSE, RUT]
CompanyLuxfer Holdings PLC
CountryUnited Kingdom
IndustrySpecialty Industrial Machinery
Market Cap283.86MEPS (ttm)-0.07
P/E-EPS this Y-7.50%
Forward P/E9.71EPS next Y47.30%
PEG-EPS past 5Y-
P/S0.70EPS next 5Y13.00%
P/B1.44EPS Q/Q-396.70%
Dividend4.91%Sales Q/Q-17.82%
Insider Own1.91%Inst Own91.22%
Insider Trans1.38%Inst Trans-2.29%
Short Float1.64%EarningsApr 30/a
Analyst Recom-Target Price-
Avg Volume185.44K52W Range7.55 - 16.58
Luxfer Holdings Plc is a global producer of engineered industrial materials, which engages in the design and manufacture of high-performance products for transportation, defense and emergency response, healthcare, and general industrial purposes. It operates through the following segments: Graphic Arts, Gas Cylinder, and Elektron. The Graphic Arts segment is involved in magnesium photo-engraving plates, engraving metals and etching chemicals. The Gas Cylinders segment manufactures and markets high-pressure aluminum and composite cylinders, systems, and accessories under the Luxfer Gas Cylinders and Superform brands. The Elektron segment focuses on specialty materials based on magnesium, zirconium, and rare earths. The company was founded in February 1996 and is headquartered in Milwaukee, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Webster StephenChief Financial OfficerNov 17 '23Buy8.461,20010,15218,025Nov 17 09:11 PM
Butcher AndrewChief Executive OfficerNov 02 '23Buy8.625,80049,967124,534Nov 03 09:03 PM
MULLEN PATRICK KDirectorOct 31 '23Buy8.3711,73598,22225,264Oct 31 06:12 PM
KYTX - Kyverna Therapeutics Inc. - Stock Price Chart
TickerKYTX [NASD]
CompanyKyverna Therapeutics Inc.
CountryUSA
IndustryBiotechnology
Market Cap716.22MEPS (ttm)-
P/E-EPS this Y96.35%
Forward P/E-EPS next Y-22.14%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own29.61%Inst Own3.27%
Insider Trans19.27%Inst Trans-
Short Float5.13%EarningsMar 26/a
Analyst Recom1.00Target Price42.75
Avg Volume504.48K52W Range13.96 - 35.06
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GILEAD SCIENCES, INC.10% OwnerFeb 12 '24Buy22.00910,00020,020,0004,126,119Feb 13 05:48 PM
Northpond Ventures III GP, LLCFormer 10% OwnerFeb 12 '24Buy22.00450,0009,900,000450,000Feb 12 05:51 PM
Bain Capital Life Sciences Inv10% OwnerFeb 12 '24Buy22.00450,0009,900,0003,163,868Feb 14 05:26 PM
Vida Ventures, LLC10% OwnerFeb 12 '24Buy22.00253,1365,568,992252,553Feb 14 07:04 PM
USNA - Usana Health Sciences Inc - Stock Price Chart
TickerUSNA [NYSE, RUT]
CompanyUsana Health Sciences Inc
CountryUSA
IndustryPackaged Foods
Market Cap876.38MEPS (ttm)3.21
P/E14.20EPS this Y-16.67%
Forward P/E14.58EPS next Y13.64%
PEG0.95EPS past 5Y-8.43%
P/S0.97EPS next 5Y15.00%
P/B1.75EPS Q/Q-9.58%
Dividend-Sales Q/Q-8.28%
Insider Own41.37%Inst Own55.41%
Insider Trans-0.46%Inst Trans-2.68%
Short Float2.31%EarningsApr 30/a
Analyst Recom3.00Target Price56.50
Avg Volume86.59K52W Range41.45 - 69.60
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ding XiaDirectorApr 24 '24Option Exercise0.0049002,646Apr 25 02:21 PM
Fleming John TurmanDirectorApr 24 '24Option Exercise0.0049003,503Apr 25 02:26 PM
FULLER GILBERT ADirectorApr 24 '24Option Exercise0.004900490Apr 25 02:28 PM
Pelosi PeggieDirectorApr 24 '24Option Exercise0.0049003,628Apr 25 02:31 PM
Nixon J ScottDirectorApr 24 '24Option Exercise0.0049002,886Apr 25 02:35 PM
ANVS - Annovis Bio Inc - Stock Price Chart
TickerANVS [NYSE]
CompanyAnnovis Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap67.27MEPS (ttm)-6.22
P/E-EPS this Y55.84%
Forward P/E-EPS next Y9.33%
PEG-EPS past 5Y-126.41%
P/S-EPS next 5Y-
P/B-EPS Q/Q-515.14%
Dividend-Sales Q/Q-
Insider Own26.05%Inst Own11.40%
Insider Trans0.00%Inst Trans-3.09%
Short Float17.85%EarningsApr 04/a
Analyst Recom1.80Target Price33.40
Avg Volume437.87K52W Range5.23 - 22.49
Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aim to treat neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Its product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Malvern, PA.
ITOS - ITeos Therapeutics Inc - Stock Price Chart
TickerITOS [NASD, RUT]
CompanyITeos Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap423.73MEPS (ttm)-3.15
P/E-EPS this Y-46.75%
Forward P/E-EPS next Y-29.55%
PEG-EPS past 5Y-40.62%
P/S33.63EPS next 5Y-
P/B0.73EPS Q/Q-257.87%
Dividend-Sales Q/Q-100.00%
Insider Own20.37%Inst Own81.06%
Insider Trans0.00%Inst Trans-2.42%
Short Float7.41%EarningsMar 06/b
Analyst Recom1.00Target Price34.40
Avg Volume283.97K52W Range8.20 - 18.24
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gall MatthewChief Financial OfficerOct 12 '23Buy8.375,00041,85019,429Oct 12 05:09 PM
Boxer Capital, LLCAug 23 '23Sale16.26350,0005,692,6731,804,058Aug 25 09:28 PM
AX - Axos Financial Inc. - Stock Price Chart
TickerAX [NYSE, RUT]
CompanyAxos Financial Inc.
CountryUSA
IndustryBanks - Regional
Market Cap3.16BEPS (ttm)7.37
P/E7.53EPS this Y51.16%
Forward P/E7.73EPS next Y-6.37%
PEG0.75EPS past 5Y16.42%
P/S1.88EPS next 5Y10.00%
P/B1.44EPS Q/Q45.02%
Dividend-Sales Q/Q40.11%
Insider Own9.87%Inst Own87.29%
Insider Trans-0.91%Inst Trans-0.38%
Short Float12.37%EarningsApr 30/a
Analyst Recom1.50Target Price68.33
Avg Volume507.61K52W Range32.05 - 60.00
Axos Financial, Inc. is a holding company, which engages in the provision of banking and financing services. It operates through the Banking Business and Securities Business segments. The Banking Business segment includes online banking, concierge banking, prepaid card services, mortgage, vehicle, unsecured lending through online, and telephonic distribution channels. The Securities Business segment involves clearing broker-dealer, registered investment advisor, and introducing broker-dealer lines of businesses. The company was founded on July 6, 1999 and is headquartered in Las Vegas, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MATSUMOTO RAYMOND DEVP, Chief Operating OfficerMar 23 '24Option Exercise52.251,86297,29030,111Mar 27 06:07 PM
Constantine Thomas MEVP, Chief Credit OfficerMar 23 '24Option Exercise52.251,50478,58420,838Mar 27 06:07 PM
Walsh DerrickEVP, Chief Financial OfficerMar 23 '24Option Exercise52.251,43374,87434,987Mar 27 06:08 PM
Swanson Brian DEVP, Head of Consumer BankMar 23 '24Option Exercise52.251,41874,09049,420Mar 27 06:08 PM
Bar-Adon EshelEVP, Chief Legal OfficerMar 23 '24Option Exercise52.251,28967,350122,143Mar 27 06:06 PM
15678910111213141520